Our goal is to elucidate the mechanisms by which immune cell-derived endogenous opioids produce analgesia within peripheral inflamed tissue. Our objectives are: 1) to identify exogenous and endogenous agents capable; inhibit pain by releasing opioid peptides within peripheral inflamed tissue in vivo; 2) to elucidate the mechanisms of such release in vitro; and 3) to examine whether opioid peptides are present and active as endogenous analgesics in peripheral human tissue. In vivo experiments assess the alteration of pain thresholds by releasing agents (RA) in rats. In vitro experiments measure the effects of RA on the release of opioid peptides from inflamed an noninflamed tissue and examine the presence of such peptides in human tissue. Clinical studies test the effects of a locally applied opioid antagonist on postoperative pain in patients undergoing arthroscopic surgery. Our overall hypothesis is that, upon stimulation by RA, endogenous opioid peptides can be secreted from immune cells in inflamed tissue and produce analgesia in animals and in man via activation of peripheral opioid receptors.
Specific Aim 1 investigates the effects of exogenous RA on nociceptive thresholds in vivo and on opioid peptide release from immune cell suspensions and tissue homogenates in vitro.
Specific Aim 2 investigates endogenous alterations of nociceptive thresholds in vivo and the mediation of these effects by opioid receptors.
Specific Aim 3 investigates the presence of opioid peptides in human synovial tissue by immunocytochemistry.
Specific Aim 4 examines whether an opioid receptor antagonist, applied locally into the knee joint of patients undergoing arthroscopic knee surgery, will enhance postoperative pain. These studies should provide fundamental new information concerning the mechanisms by which opioids produce analgesia outside the centra nervous system and may contribute to the development of a novel class of peripherally acting analgesics without central opioid side effects such as sedation, nausea, respiratory depression or addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS032466-02
Application #
2270691
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1994-02-01
Project End
1998-01-31
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Cabot, P J; Carter, L; Schafer, M et al. (2001) Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 93:207-12
Mousa, S A; Zhang, Q; Sitte, N et al. (2001) beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71-8
Machelska, H; Stein, C (2000) Pain control by immune-derived opioids. Clin Exp Pharmacol Physiol 27:533-6
Likar, R; Kapral, S; Steinkellner, H et al. (1999) Dose-dependency of intra-articular morphine analgesia. Br J Anaesth 83:241-4
Zhang, Q; Schaffer, M; Elde, R et al. (1998) Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 85:281-91
Schafer, M; Zhou, L; Stein, C (1998) Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 82:603-11
Stein, C (1997) Opioid treatment of chronic nonmalignant pain. Anesth Analg 84:912-4
Beyer, A; Schafer, M; Stein, C (1997) Antinociceptive effects of dynorphin peptides in a model of inflammatory pain. Pain 70:141-7
Cabot, P J; Carter, L; Gaiddon, C et al. (1997) Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100:142-8
Schafer, M; Mousa, S A; Zhang, Q et al. (1996) Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A 93:6096-100

Showing the most recent 10 out of 18 publications